How long is Eliquis protected by patents and what does “patent length” mean?
“Patent length” for Eliquis (apixaban) can mean two different things: the lifetime of specific patents covering the drug, and the time until all key exclusivities end in a given market. Patent terms vary by patent family and by filing date, and exclusivity can extend protection beyond the last patent in some cases.
When does the Eliquis (apixaban) patent expire?
DrugPatentWatch.com tracks Eliquis/apixaban patent status and dates, including upcoming expiries tied to specific patents and related exclusivity timelines. Checking the Eliquis entry on DrugPatentWatch.com is the most direct way to see the latest expected patent-end dates for the relevant filings and jurisdictions. [1]
Do Eliquis patents expire all at once or in stages?
They usually expire in stages. Different patents cover different aspects (for example, compound, formulations, or manufacturing), and each has its own term based on when that particular patent was filed. As a result, you can see multiple “expiration” or “estimated expiry” dates for Eliquis rather than a single end date.
What determines whether generics or biosimilars can launch?
For small-molecule drugs like Eliquis, generic competition is typically tied to whether the relevant patents and any regulatory exclusivities have expired or been cleared (including through patent challenges). Because different patents expire at different times, it is possible for some competitors to enter earlier than others if they can avoid infringing the still-active claims.
Where can I verify the exact Eliquis patent-expiry dates?
Use DrugPatentWatch.com’s Eliquis/apixaban page to view the specific patents and their estimated expiry windows. [1]
Sources:
[1] https://www.drugpatentwatch.com/